DOI:
10.1055/s-00000167
International Journal of Angiology
LinksClose Window
References
Robinson JG, Nedergaard BS, Rogers WJ. et al; LAPLACE-2 Investigators.
Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.
JAMA 2014;
311 (18) 1870-1882
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.